These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND ETV5, P41161, 2119, ENSG00000244405, ERM AND Prognosis
5 results:

  • 1. Clinicopathological Features and prognosis of Gastrointestinal Metastases From Breast Carcinoma: A Clinicopathological Study of 22 Patients.
    Wang S; Li W; Li S; Liu X; Zhang L; Hao C; Meng W; Zhao W; Tong Z
    Int J Surg Pathol; 2023 Sep; 31(6):1075-1084. PubMed ID: 36803140
    [No Abstract]    [Full Text] [Related]  

  • 2. ETV1 Positively Correlated With Immune Infiltration and Poor Clinical prognosis in colorectal cancer.
    Shen X; Zhou C; Feng H; Li J; Xia T; Cheng X; Zhao R; Zou D
    Front Immunol; 2022; 13():939806. PubMed ID: 35860243
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The role of E26 transformation-specific variant transcription factor 5 in colorectal cancer cell proliferation and cell cycle progression.
    Peng Y; Feng H; Wang C; Song Z; Zhang Y; Liu K; Cheng X; Zhao R
    Cell Death Dis; 2021 Apr; 12(5):427. PubMed ID: 33931578
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Targeting tumor cell-derived CCL2 as a strategy to overcome Bevacizumab resistance in etv5
    Feng H; Liu K; Shen X; Liang J; Wang C; Qiu W; Cheng X; Zhao R
    Cell Death Dis; 2020 Oct; 11(10):916. PubMed ID: 33099574
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Ezrin expression is an independent prognostic factor in gastro-intestinal cancers.
    Arumugam P; Partelli S; Coleman SJ; Cataldo I; Beghelli S; Bassi C; Wijesuriya N; Aleong JA; Froeling FE; Scarpa A; Kocher HM
    J Gastrointest Surg; 2013 Dec; 17(12):2082-91. PubMed ID: 24155054
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.